MigraineMind research summary
Comparison of greater occipital and supraorbital nerve block with amitriptyline use in migraine treatment.
Dusunen Adam | 2024
Observational studySummary
Migraine is a condition that often requires long-term preventive therapy. This study compares the effectiveness of greater occipital nerve (GON) and supraorbital nerve (SON) blockades against amitriptyline in managing migraines. Researchers included 57 patients diagnosed with migraines in this retrospective study. One group received 25 mg of amitriptyline daily for six months. The other group received GON and SON blockades weekly for one month. They then continued with monthly blockades for five months. Pain frequency, analgesic use, and Visual Analog Scale (VAS) scores were assessed. Both groups showed reduced pain frequency and fewer painful days over time. Significant differences were noted at all time points compared to baseline. Notably, GON and SON blockades resulted in lower VAS scores than amitriptyline. This study indicates that GON and SON blockades could be effective as migraine prophylaxis. They may serve as a valuable alternative to amitriptyline therapy. Clinical relevance: This research suggests that GON and SON blockades may effectively prevent migraines, offering an alternative to traditional amitriptyline treatment.
Key Learning Points
- Migraine often requires long-term treatment, and effective options are essential for managing this condition.
- Greater occipital nerve and supraorbital nerve blockades can significantly reduce migraine pain compared to traditional medication.
- Both GON and SON blockades showed better results in pain severity than amitriptyline over the study period.
- Patients receiving nerve blockades experienced fewer painful days and reduced need for analgesics.
- This study highlights the potential of nerve blockades as a viable alternative for migraine prevention.
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.